PDT + anti-PD-1/PD-L1 combinations show enhanced control of primary tumours and metastasis and are a harbinger of ablative effects; this is a direction with high translational potential for early phase studies in immunologically ‘cold’ tumours [61,62]. This evidence concerns the gene CD274 and neoplasm.